The largest database of trusted experimental protocols

Edta containing tubes

Manufactured by BD
Sourced in United States, United Kingdom, France

EDTA-containing tubes are laboratory equipment designed to collect and store blood samples. EDTA, or ethylenediaminetetraacetic acid, is an anticoagulant that prevents the blood from clotting, allowing for accurate analysis of the sample. These tubes are commonly used in various medical and research settings to prepare blood specimens for further testing and examination.

Automatically generated - may contain errors

40 protocols using edta containing tubes

1

Isolation and Activation of M1 Macrophages

Check if the same lab product or an alternative is used in the 5 most similar protocols
Blood samples (30 ml each) from the patients with nvAMD were collected into EDTA-containing tubes (BD Biosciences). Monocytes were isolated from the whole blood samples, differentiated into M0 macrophages, and then activated to form M1 macrophages by stimulation with IFN-γ and LPS as previously described [11 (link),24 (link)-28 (link)]. We chose this specific macrophage subtype because we previously found that M1 macrophages cause increased neovascularization in vitro and in vivo [11 (link)]. The medium was harvested from the cultured macrophages and stored at −20 °C for use in the choroid sprouting assay (CSA). Macrophages were collected using 0.25% trypsin (Sigma-Aldrich, Munich, Germany), washed with RPMI 1640 medium (Biological Industries Israel Beit Haemek Ltd) containing fetal calf serum (FCS), washed 3 times with phosphate-buffered saline (1X PBS; 135 mM NaCl, 2.7 mM KCl, 10 mM Na2PO4, 1.5 mM KH2PO4, pH 7.4), and used immediately in the in vivo experiments.
+ Open protocol
+ Expand
2

Plasma miRNA Extraction and Quantification

Check if the same lab product or an alternative is used in the 5 most similar protocols
Blood samples were collected from the antecubital vein after an overnight fast into EDTA containing tubes (BD Bioscience, Franklin Lakes, NJ, USA). Blood was centrifuged at 600 x g for 20 minutes at 4°C. Plasma was removed and centrifuged at 1500 x g for 15 minutes at 4°C to remove any additional cellular debris. Platelet poor plasma was aliquoted and stored at −80°C for batch analysis.
Total RNA was isolated from platelet poor plasma using the miRNeasy Serum/Plasma Kit (Qiagen, Hilden, Germany)9 (link). Briefly, RNA was isolated from 100μL of plasma using the QIAsol lysis reagent, washed and eluted in RNAse free water. To normalize between samples 3.5μL (1.6x108 copies/μL) Canorhabditis elegans miR-39 (cel-miR-39) was added to each sample9 (link). Immediately after RNA isolation, 12μL of RNA was reverse transcribed using the miScript Reverse Transcription Kit (Qiagen, Hilden, German)9 (link),10 (link). cDNA was PCR-amplified (BioRad CFX96 Touch Real Time System) using the miScript SYBR green PCR kit (Qiagen, Hilden, Germany) and miRNA specific primers for miR-17, miR-21, miR-34a, miR-92a, miR-126, miR-145, miR-146a and miR-150 (Qiagen, Hilden, Germany)10 (link). All samples were assayed in duplicate. Relative expression level for a given miR was normalized to cel-miR-39, calculated as ΔCt =2−(Ct[miR]-Ct[cel-miR-39]) and expressed as arbitrary units (AU)9 (link),10 (link).
+ Open protocol
+ Expand
3

Plasma Circulating Bacterial DNA Isolation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Fresh blood samples or endotoxin-free water (negative control, Catalog number: W50-640, LONZA, Walkersville, MD, United States) in EDTA-containing tubes (BD, San Jose, CA, United States) were centrifuged at 800 g for 15min, which was followed by transferring the samples to new centrifuge tubes (Catalog number: 352098, BD). Plasma and water controls were placed in aliquots and stored at −80°C. DNA low-binding centrifuge tubes (Catalog number: 022431021, Eppendorf, Hamburg, Germany) were used to store the plasma samples. We avoided repeated freezing and thawing before microbial 16S rDNA isolation. Circulating bacterial DNA was extracted from 400 μl of plasma or the water control using the QIAamp UCP Pathogen Mini Kit (Catalog number: 50214, Qiagen, United States) according to the manufacturer’s instructions.
+ Open protocol
+ Expand
4

Isolation and Identification of Circulating Tumor Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
We collected 10-mL peripheral blood samples from all patients in the morning using EDTA-containing tubes (BD, USA), then mixed 7.5-mL blood samples with 6.5 mL of buffer and centrifuged the mixture at 8000 g for 10 min. The supernatant plasma was kept and mixed with buffer and immune-magnetic beads. After incubation at room temperature for 20 min, immune assay was performed. Excess reaction buffer and unresponsive magnetic beads were removed, and cells were washed from beads by elution buffer. Partial cell suspension liquids were mixed with APC-labelled CD45 antibody, PE-labelled CK8/18/19 antibody, and DAPI dye for staining. Excess dyes and antibody were removed. Stained cells were added into the MagNest sample chamber, which was incubated in the dark for 30 min. Within the MagNest sample chamber, cells dispersed into the analytical layer. CTCs were identified as CD45-CK+DAPI+. In morphology, CTCs showed clear cell contour, evenly distributed in plasma at more than 1 nucleus/cytoplasm ratio.
+ Open protocol
+ Expand
5

Plasma RNA Extraction from AIS Patients

Check if the same lab product or an alternative is used in the 5 most similar protocols
Blood samples from AIS patients were collected at arrival of hospital. Whole blood was drawn into EDTA-containing tubes (BD Biosciences) prior to the administration of any therapies. The samples were processed by centrifugation at 1000 × g for 10 min at 4°C. Total RNA was extracted from the plasma of every AIS patient using a miRNeasy Mini kit (Qiagen) according to the manufacturer’s protocol and was quantified using a NanoDrop ND-1000 spectrophotometer (Thermo Fisher Scientific, Waltham, MA, U.S.A.).
+ Open protocol
+ Expand
6

Oral Glucose Tolerance Test Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
At baseline and 12 wk, a standard oral-glucose-tolerance test (OGTT) was administered following a 12-h overnight fast. Participants rested for ≥30 min prior to the insertion of a Teflon catheter into an antecubital vein for repeated blood sampling and remained patent by a 0.9% saline drip. After baseline blood collection, participants ingested 75 g glucose bolus (NOW foods) dissolved in 250 mL of water within 2 min (t = 0 min) (21 (link)). Venous blood was collected at the following time points: 0, 15, 30, 45, 60, 90, and 120 min after glucose ingestion into EDTA containing tubes (BD Biosciences). Blood glucose concentration was determined using a biochemical analyzer (YSI 2900 Life Sciences) in duplicate and subsequently centrifuged at 1000 × g for 10 min at 4°C. Aliquots of plasma were frozen and stored at –20°C until analyses. Plasma insulin concentrations were determined using a commercially available ELISA (ALPCO).
Plasma glucose and insulin concentrations were used to determine the Matsuda index and HOMA-IR according to established formulas (23 (link), 24 (link)). The Matsuda index was calculated by:

HOMA-IR was calculated by:

Further, the insulinogenic index (IGI) was utilized as a measure of β-cell function and calculated as ratio of insulin concentration at 30 min minus fasting insulin to the difference of glucose at the same time (25 (link)).
+ Open protocol
+ Expand
7

Peripheral Blood Cell Counts

Check if the same lab product or an alternative is used in the 5 most similar protocols
White blood cells- and neutrophil-counts were determined in peripheral blood. Samples at a volume of 50 μL were collected from the tail vein of mice into EDTA containing tubes (BD, Franklin Lakes, NJ, USA) and were analyzed using Veterinary Multi-species Hematology System Hemavet 850 (Drew Scientific, Miami Lakes, FL, USA).
+ Open protocol
+ Expand
8

Plasma Isolation from EDTA Blood

Check if the same lab product or an alternative is used in the 5 most similar protocols
Blood samples were collected in ethylenediaminetetraacetic acid (EDTA) containing tubes (BD, Franklin Lakes, NJ, USA). Plasma was isolated within 1 h using centrifugation at 1900 ×g for 10 min at 4°C to remove blood cells, and then at 16,000 ×g for 10 min at 4°C to remove additional cellular nucleic acid attached to cell debris. Plasma samples were transferred to RNase/DNase-free tubes and stored at −80°C.
+ Open protocol
+ Expand
9

Venous Blood Sampling and Leukocyte Isolation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Venous blood samples were collected via antecubital venipuncture from each subject within 3–5 h of the onset of symptoms but before arteriography. Whole blood samples (2 mL) were collected directly into EDTA-containing tubes (BD, Franklin Lakes, NJ, USA), and three volumes of red blood cell lysis buffer (NH4CL2009; Haoyang, Tianjin, China) was added to obtain leukocytes, which were isolated within 2 h by centrifugation at 3000 rpm for 5 min at 4 °C to remove other blood elements. Next, 1 mL TRIzol (15596–026; Invitrogen Life Technologies) was added, and samples were then transferred to RNase/Dnase-free tubes and stored at −80 °C.
+ Open protocol
+ Expand
10

Plasma Isolation for Nucleic Acid Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Blood samples were collected in EDTA-containing tubes (BD, Franklin Lakes, NJ, USA) and plasma was isolated within 1 hour by centrifugation at 1900 × g for 10 minutes at 4°C to remove blood cells, and then at 16,000 × g for 10 minutes at 4°C to remove additional cellular nucleic acid attached to cell debris. Plasma samples were stored at −80°C prior to being analyzed.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!